Stay updated on Maplirpacept in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FxwDAxohl1VGJtJPC6ttSBXN1l68.uncropped.jpg&w=3840&q=75)
Latest updates to the Maplirpacept in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedPfizer has terminated the study, clarifying that the decision was not influenced by safety concerns or regulatory requests, while the previous status of 'Active, not recruiting' has been removed.SummaryDifference8%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check30 days agoNo Change Detected
- Check44 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.3%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to Maplirpacept in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.